BP
INVA icon

Ballentine Partners’s Innoviva INVA Stock Holding History

Ballentine Partners’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
13,442
+475
+4% +$10.9K ﹤0.01% 781
2026
Q1 		$302K Sell
12,967
-2,815
-18% -$60.6K ﹤0.01% 736
2025
Q4 		$315K Sell
15,782
-1,746
-10% -$34.1K ﹤0.01% 702
2025
Q3 		$320K Buy
17,528
+102
+0.6% +$1.99K ﹤0.01% 687
2025
Q2 		$350K Buy
+17,426
New +$335K 0.01% 622

Other funds holding INVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Ballentine Partners's INVA Position: Q2 2026 in Review

Ballentine Partners increased its Innoviva (INVA) stake by 3.7% in Q2 2026, buying an estimated $10.9K and bringing the position to 13,442 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #781.

Ballentine Partners first reported a position in INVA in Q2 2025 and has held it in 5 quarters since. The position peaked at $350K in Q2 2025. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Ballentine Partners held 13,442 shares of Innoviva worth $305K as of Q2 2026.
  • Ballentine Partners bought 475 Innoviva shares in Q2 2026, an estimated $10.9K.
  • Innoviva made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #781 holding.
  • Ballentine Partners first reported a position in Innoviva in Q2 2025 and has held it in 5 quarters since.
  • Ballentine Partners's Innoviva position peaked at $350K in Q2 2025.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.